跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPI-6
首页
药物
EPI-6
EPI-6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
FUNGAL-DERIVED ENZYME COMPOSITION AND METHOD FOR TREATING EXOCRINE PANCREATIC INSUFFICIENCY
US 20260158120 A1
申请人: HILLEY HENRY
优先权: 2024
US
WO
2 件公开
Lipoxin analogs as novel inhibitors of angiogenesis
US 8722654 B2
申请人: SERHAN CHARLES N
优先权: 2011
US
2 件公开
Suspension of EPI-HNE-4, dry powder aerosol derived therefrom, process of preparation thereof, pharmaceutical compositions containing said suspension or aerosol, and their uses
EP 1201249 A1
申请人: DEBIOPHARM SA
优先权: 2000
EP
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
US 6884429 B2
申请人: ISOTECHNIKA INTERNAT INC
优先权: 2002
US
Process to prepare malayamycin derivatives
US 2006149064 A1
申请人: HANESSIAN STEPHEN
优先权: 2003
US
Vitamin d analogues, compositions comprising said analogues and their use
US 2006166949 A1
申请人: LEO PHARMA AS
优先权: 2003
US
Influenza virus resisting nasal mucosa absorbent and preparation thereof
CN 101214226 A
申请人: WENJIE TAN
优先权: 2008
CN
USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS
US 2010105772 A1
申请人: SERHAN CHARLES N
优先权: 2009
US
Simian foamy virus recombinant antigen ELISA (Enzyme-Linked Immunosorbent Assay) detection method and reagent kit
CN 101876660 A
申请人: NAT INST FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOG PRODUCT
优先权: 2010
CN
Asymmetric synthesis method for natural products Aculeatins A, B, D and 6-epi-Aculeatin D
CN 105294725 A
申请人: UNIV JIANGXI NORMAL SCI & TECH
优先权: 2015
CN
第 1 / 3 页
上一页
下一页
药物
反馈